<DOC>
	<DOCNO>NCT02097797</DOCNO>
	<brief_summary>Crohn 's disease chronic relapse inflammatory bowel disease . Many data show intestinal flora involve disease show patient Crohn 's disease exhibit abnormal fecal flora might play role inflammation . The purpose study determine effect fecal flora transplantation Crohn 's disease .</brief_summary>
	<brief_title>Impact Fecal Flora Transplantation Crohn 's Disease</brief_title>
	<detailed_description>Introduction : Crohn 's disease ( CD ) relapse inflammatory bowel disease relatively frequent . Its prevalence 1 700 France , affect predominantly young adult . Its treatment base immunosuppressant might associate potentially severe complication infection cancer . Moreover , treatment expensive . The gut microbiota involve disease pathogenesis , consider potential therapeutic target . CD pathogenesis remain poorly understood involves inappropriate immune response toward unbalanced gut microbiota ( call dysbiosis ) predispose host . The complete replacement dysbiotic microbiota `` healthy '' one thus attractive strategy . Fecal transplantation ( FT ) use success long time context Clostridium difficile . Hypothesis : Fecal transplantation allow replacement dysbiotic microbiota `` healthy `` one favorable impact CD evolution . Primary endpoint : In CD patient colonic ileo-colonic involvement put remission corticosteroid , Evaluate FT modify dysbiotic fecal microbiota closer one healthy donor . Methodology For Receiver : Once corticoid-induced remission achieve , patient include randomised receive either FT sham transplantation colonoscopy . The patient evaluate week 2 , 6 , 10 , 14 , 18 24 . At week 6 , colonoscopy perform . For Donor : Donors recruit poster advertising . When receiver include , 3 donor contact attend inclusion visit include physical examination well blood stool screen pathogen . The 3 donor come day FT donate stool .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Receiver Age &gt; 18 year &lt; 70 year Crohn 's disease colonic ileocolonic involvement Active disease screening define Harvey Bradshaw Index &gt; 4 Clinical remission ( Harvey Bradshaw Index &lt; 5 ) 3 week follow corticosteroid onset Patient health insurance Written consent obtain Fistulizing disease Anoperineal abdominal abscess Complication require surgical treatment Treatment antiTNFa ( ongoing stop 1 month precede randomization ) Immunosuppressant treatment start stop 3 month precede randomization Nonsteroidal anti inflammatory drug ( NSAIDs ) intake 4 week precede randomization Antibiotics antifungic treatment 4 week precede colonoscopy Probiotics intake 4 week precede colonoscopy Clostridium difficile infection 10 day precede randomization contraindication colonoscopy anesthesia Pregnancy Donor Age &gt; 20 year &lt; 50 year 27kg/m² &gt; BMI &gt; 17 kg/m² Regular bowel movement usually one bowel movement morning Subject health insurance Written consent obtain Infection risk : Known infection human immunodeficiency virus ( HIV ) , Human T Leukemia Virus ( HTLV ) , Hepatitis B C virus . At risk behavior : Travel ( precede 3 month , except Euro area , United Kingdom , Bulgaria , Poland , Romania , Croatia , Hungary , Republic Tcheque , Denmark , Norway , Sweden , Swiss , USA Canada ) , risk sexual activity ( intercourse without protection new partner ) precede 6 month , blood transfusion , pierce tattoo precede 6 month residence several year intertropical area , abroad hospitalization 24 hour last 12 month ( include patient immediate family ) . Positive result one screening test infectious disease . : HIV , HCV , HBV , HTLV , syphilis , Enteric virus ( Rotavirus , HEV , Adenovirus , Norovirus , Enterovirus , HAV , Poliovirus , Astrovirus , Aichi virus , Sapovirus ) , parasites stool ( Cyclospora , Isospora , Cryptosporidium , Microsporidium , Strongyloides stercoralis , Entamoeba histolitica , Giardia intestinalis , Dientamoeba fragilis ) , blood ( Strongyloides stercoralis , Trichinella spiralis , Amoebiasis ) , pathogenic bacteria stool ( Clostridium difficile , Shigella , Campylobacter , Yersinia , Salmonella , Listeria monocytogenes , Vibrio cholerae/parahemolyticus , verotoxinproducing E. coli ) Anal lesion suggest viral infection positive test HSV anal and/or multidrug resistant bacteria ( Enterobacteria produce extend spectrum betalactamase , Actinobacter baumanii , Vancomycin resistant enterococci carbapenemase produce bacteria ) . Positive test multidrug resistant bacteria If receiver EBV negative , EBV positive donor exclude If receiver CMV negative , CMV positive donor exclude . If receiver negative Toxoplasma gondii , positive donor Toxoplasma gondii exclude Known transmissible infectious disease Infection ( possible infection ) 7 day precede screen Risk factor CreutzfeldtJakob disease Personal history Typhoid fever Gastrointestinal comorbidity Personal history first degree relative : Inflammatory bowel disease Coeliac disease Personal history irritable bowel syndrome , chronic constipation , chronic diarrhea Personal history gastrointestinal neoplasia polyposis First degree relative gastrointestinal neoplasia polyposis 60 year old Gastrointestinal infection 3 preceding month ( define occurrence acute diarrhea last less week ) Factors possibly affect composition microbiota : Antibiotics antifungic intake 3 precede month FT Nonsteroidal anti inflammatory drug ( NSAIDs ) intake 4 week precede FT Specific diet ( exclusion diet , vegetarian diet ) Pregnancy Immunosuppressant intake ( corticosteroid , calcineurin inhibitor , biologics , etc ) Anti neoplastic chemotherapy Hemorrhoid disease Personal history first degree relative inflammatory autoimmune disease Other Factors : Known chronic disease Abnormality initial biological check : blood cell count , fasting , glycaemia , kidney function , liver test , haemostasis , calprotectin Long term curative therapy Recent intake food allergen relate receiver 's know allergy screen FT : At risk behavior ( Travel , risk sexual activity , blood transfusion , pierce tattoo , accidental blood exposure ) Anal lesion suggestive viral infection positivity HSV anal area Infection possible infection Occurrence gastrointestinal symptom Medicine intake 48 hour precede FT ( except contraceptive ) In case woman : menstruation 48 hour precede FT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Inflammatory bowel disease</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>microbiota</keyword>
	<keyword>fecal transplantation</keyword>
</DOC>